(1 - 15 from 23
)
Cempra commences CEM-102 Phase II PJI trial - Clinical ...www.clinicaltrialsarena.com › uncategorized › newscempra-commenc...
www.clinicaltrialsarena.com
FIDSA clinical research senior vice president Dr David Oldach said the all-oral antibiotic regimen allows the treatment of PJI offering convenient ...
Cempra Announces Positive Topline Phase 3 Clinical Results for Oral...
www.globenewswire.com
"I congratulate Dr. David Oldach, senior vice president of Clinical Research, his clinical group and the entire Cempra team for running this ...
Cempra to Present Solithromycin Data at ID Week 2015
www.globenewswire.com
... Global Phase 3 Clinical Trial for Solithromycin – Poster Number 893, presented by David Oldach, M.D., FIDSA. The abstract is available here.
Cempra to Present at Two Upcoming Scientific Conferences Nasdaq:CEMP
www.globenewswire.com
... from latest clinical trial, April 28, oral presentation by David Oldach at 11:54 a.m. CET in Hall E. An abstract for the late breaker presentation is ...
sorted by relevance / date